Research Links Alpha-Gal Syndrome to Allergic Transfusion Risks

New research published in JAMA Internal Medicine suggests alpha-gal syndrome (AGS) is a potential risk factor for allergic transfusion reactions, particularly in Type O patients residing in high-prevalence areas. The findings propose that avoiding group B or AB platelet and plasma products in these patients could enhance transfusion safety and inform future medical practices.